CalAmp Reports Third Quarter Fiscal Year 2022 Financial Results

Stock Information for CAMP4 Therapeutics Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CAMP4 Therapeutics Corporation

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
CAMP4 to Participate in Upcoming Investor Conferences
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.